Recro Pharma Inc (NASDAQ:REPH) Receives Consensus Recommendation of “Buy” from Brokerages
Shares of Recro Pharma Inc (NASDAQ:REPH) have received a consensus rating of “Buy” from the seven brokerages that are covering the company, MarketBeat.com reports. Three investment analysts have rated the...









